Business News

Granules India expecting sole first to file status on Ruxolitinib Extended-Release Tablets

Thursday, October 8, 2026 - 16:12
0 1
Granules India expecting sole first to file status on Ruxolitinib Extended-Release Tablets
If confirmed by the FDA and all applicable statutory and regulatory requirements are satisfied, first-to-file status may provide eligibility for 180 days of generic drug exclusivity under US law

Read More
Previous Article

Brookfield to acquire ESR India’s industrial and logistics portfolio

Next Article

University of Colorado Denver to set up India campus in Hyderabad

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Related Posts

IMD issues red alert for 5 districts in Keralam on Oct 25, 26

IMD issues red alert for 5 districts in Keralam on O...

Saturday, October 24, 2026
0
1
Odisha moves Supreme Court against Andhra Pradesh over rural poll notice in Kotia area

Odisha moves Supreme Court against Andhra Pradesh ov...

Saturday, October 24, 2026
0
1
US says Russia, Ukraine to let civilians leave war-torn area

US says Russia, Ukraine to let civilians leave war-t...

Saturday, October 24, 2026
0
1
PM Modi to visit Uttar Pradesh and Odisha on October 25

PM Modi to visit Uttar Pradesh and Odisha on October 25

Saturday, October 24, 2026
0
1
Chennai airport ATF tax cut to 16% from 29%; rate slashed to 1% for other TN airports

Chennai airport ATF tax cut to 16% from 29%; rate sl...

Saturday, October 24, 2026
0
0
Courts cannot be unmindful when precious water bodies remain unprotected: SC

Courts cannot be unmindful when precious water bodie...

Saturday, October 24, 2026
0
1

Comments (0)

User